Review of Pain Management with Clinical and Regulatory...
Transcript of Review of Pain Management with Clinical and Regulatory...
![Page 1: Review of Pain Management with Clinical and Regulatory …capewayne.med.wayne.edu/pdfs/review_of_pain...Clinical and Regulatory Updates Palliative Care Collaborative: 8th Annual Regional](https://reader035.fdocuments.us/reader035/viewer/2022062610/61206af755615573614597e4/html5/thumbnails/1.jpg)
Review of Pain Management with Clinical and Regulatory Updates
Palliative Care Collaborative: 8th Annual Regional Conference October 10, 2014
Michael Stellini, M.D.,M.S.
Medical Director, Hospice and Palliative Care John D. Dingell Veterans Administration Hospital
Detroit , Michigan
![Page 2: Review of Pain Management with Clinical and Regulatory …capewayne.med.wayne.edu/pdfs/review_of_pain...Clinical and Regulatory Updates Palliative Care Collaborative: 8th Annual Regional](https://reader035.fdocuments.us/reader035/viewer/2022062610/61206af755615573614597e4/html5/thumbnails/2.jpg)
Disclosure
• Dr. Stellini has no financial or other conflicts of interest related to this presentation to report.
• Any mention of off-label use of drugs will be identified as such.
![Page 3: Review of Pain Management with Clinical and Regulatory …capewayne.med.wayne.edu/pdfs/review_of_pain...Clinical and Regulatory Updates Palliative Care Collaborative: 8th Annual Regional](https://reader035.fdocuments.us/reader035/viewer/2022062610/61206af755615573614597e4/html5/thumbnails/3.jpg)
Objectives
• Attendees will know general techniques of pharmacological and non-pharmacological treatment of pain
• Attendees will be aware of recent changes in scheduling of opioids and their effect on access to medications for patients
• Attendees will know the rationale and impact of FDA initiatives to control diversion and harmful effects of opioids
![Page 4: Review of Pain Management with Clinical and Regulatory …capewayne.med.wayne.edu/pdfs/review_of_pain...Clinical and Regulatory Updates Palliative Care Collaborative: 8th Annual Regional](https://reader035.fdocuments.us/reader035/viewer/2022062610/61206af755615573614597e4/html5/thumbnails/4.jpg)
PALLIATION
The physician’s duty is to cure when possible, relieve suffering often, comfort always.
![Page 5: Review of Pain Management with Clinical and Regulatory …capewayne.med.wayne.edu/pdfs/review_of_pain...Clinical and Regulatory Updates Palliative Care Collaborative: 8th Annual Regional](https://reader035.fdocuments.us/reader035/viewer/2022062610/61206af755615573614597e4/html5/thumbnails/5.jpg)
• Pain is part of suffering
• Physical pain is part of total pain
![Page 6: Review of Pain Management with Clinical and Regulatory …capewayne.med.wayne.edu/pdfs/review_of_pain...Clinical and Regulatory Updates Palliative Care Collaborative: 8th Annual Regional](https://reader035.fdocuments.us/reader035/viewer/2022062610/61206af755615573614597e4/html5/thumbnails/6.jpg)
How do we assess pain?
• Verbal report –
0-10 scale
Benefit – changes over time (with or w/o tx)
Limitations – person specific, cognitive
impairment, “numbers challenged”
“How are we doing with your pain control?”
![Page 7: Review of Pain Management with Clinical and Regulatory …capewayne.med.wayne.edu/pdfs/review_of_pain...Clinical and Regulatory Updates Palliative Care Collaborative: 8th Annual Regional](https://reader035.fdocuments.us/reader035/viewer/2022062610/61206af755615573614597e4/html5/thumbnails/7.jpg)
How do we assess pain?
• Observation
• e.g. Pain Assessment Behavior Scale
Grimacing, Restlessness, Consolability,etc
• A lot of non-verbal patients are in pain
Dementia, delirium, encephalopathy,
intubated, children, etc.
![Page 8: Review of Pain Management with Clinical and Regulatory …capewayne.med.wayne.edu/pdfs/review_of_pain...Clinical and Regulatory Updates Palliative Care Collaborative: 8th Annual Regional](https://reader035.fdocuments.us/reader035/viewer/2022062610/61206af755615573614597e4/html5/thumbnails/8.jpg)
What kind of pain is it?
• Acute pain – injury, post-op
• Chronic malignant pain
• Non-malignant chronic pain
![Page 9: Review of Pain Management with Clinical and Regulatory …capewayne.med.wayne.edu/pdfs/review_of_pain...Clinical and Regulatory Updates Palliative Care Collaborative: 8th Annual Regional](https://reader035.fdocuments.us/reader035/viewer/2022062610/61206af755615573614597e4/html5/thumbnails/9.jpg)
What kind of pain is it?
• Somatic
• Visceral
• Neuropathic
• Combined
![Page 10: Review of Pain Management with Clinical and Regulatory …capewayne.med.wayne.edu/pdfs/review_of_pain...Clinical and Regulatory Updates Palliative Care Collaborative: 8th Annual Regional](https://reader035.fdocuments.us/reader035/viewer/2022062610/61206af755615573614597e4/html5/thumbnails/10.jpg)
Components of Pain
• Physical
• Psycological
• Spiritual
![Page 11: Review of Pain Management with Clinical and Regulatory …capewayne.med.wayne.edu/pdfs/review_of_pain...Clinical and Regulatory Updates Palliative Care Collaborative: 8th Annual Regional](https://reader035.fdocuments.us/reader035/viewer/2022062610/61206af755615573614597e4/html5/thumbnails/11.jpg)
INTERVENTIONS FOR PAIN CONTROL
![Page 12: Review of Pain Management with Clinical and Regulatory …capewayne.med.wayne.edu/pdfs/review_of_pain...Clinical and Regulatory Updates Palliative Care Collaborative: 8th Annual Regional](https://reader035.fdocuments.us/reader035/viewer/2022062610/61206af755615573614597e4/html5/thumbnails/12.jpg)
Non-Pharmacological Treatment
• Physical Therapy
• Heat
• Acupuncture
• Relaxation, Biofeedback, Imagery
• Counseling, Psychotherapy
• TENS
• Chiropractic
• Aromatherapy
• “Healing Touch”
![Page 13: Review of Pain Management with Clinical and Regulatory …capewayne.med.wayne.edu/pdfs/review_of_pain...Clinical and Regulatory Updates Palliative Care Collaborative: 8th Annual Regional](https://reader035.fdocuments.us/reader035/viewer/2022062610/61206af755615573614597e4/html5/thumbnails/13.jpg)
Pharmacologic Interventions
![Page 14: Review of Pain Management with Clinical and Regulatory …capewayne.med.wayne.edu/pdfs/review_of_pain...Clinical and Regulatory Updates Palliative Care Collaborative: 8th Annual Regional](https://reader035.fdocuments.us/reader035/viewer/2022062610/61206af755615573614597e4/html5/thumbnails/14.jpg)
Before we try assisted
suicide, Mrs. Rose, let’s give
aspirin a chance.
![Page 15: Review of Pain Management with Clinical and Regulatory …capewayne.med.wayne.edu/pdfs/review_of_pain...Clinical and Regulatory Updates Palliative Care Collaborative: 8th Annual Regional](https://reader035.fdocuments.us/reader035/viewer/2022062610/61206af755615573614597e4/html5/thumbnails/15.jpg)
Non-Opioid Analgesics
• Acetaminophen (analgesic, anti-pyretic, renal, liver toxicity)
• ASA (analgesic, anti-pyretic, anti-inflammatory, anti-platelet, Toxicities:GI, ulcer, bleeding ,renal, Reyes)
• NSAIDS (see aspirin) 17 compounds in clinical use in U.S. Ketorolac (Toradol) • COX-2 inhibitors (1 currently on market) analgesic, anti-
pyretic, anti-inflammatory, little anti-platelet activity) • Tramadol (Ultram ) (lowers seizure threshold, drug-drug
interactions) • Lidocaine Patch (Lidoderm) • Capscacin • Topical NSAIDS • Cannabinoids? (Sativex)
![Page 16: Review of Pain Management with Clinical and Regulatory …capewayne.med.wayne.edu/pdfs/review_of_pain...Clinical and Regulatory Updates Palliative Care Collaborative: 8th Annual Regional](https://reader035.fdocuments.us/reader035/viewer/2022062610/61206af755615573614597e4/html5/thumbnails/16.jpg)
Morphine
• Conjugated in liver.
• Morphine glucuronide is active.
• Excreted in urine.
• Decrease dose with renal impairment.
• May want to titrate dose down near end of life because of renal shut-down.
![Page 17: Review of Pain Management with Clinical and Regulatory …capewayne.med.wayne.edu/pdfs/review_of_pain...Clinical and Regulatory Updates Palliative Care Collaborative: 8th Annual Regional](https://reader035.fdocuments.us/reader035/viewer/2022062610/61206af755615573614597e4/html5/thumbnails/17.jpg)
Hydromorphone
• More potent than morphine
• Oral or IV
• Safer in renal disease
• Mostly hepatic metabolism
![Page 18: Review of Pain Management with Clinical and Regulatory …capewayne.med.wayne.edu/pdfs/review_of_pain...Clinical and Regulatory Updates Palliative Care Collaborative: 8th Annual Regional](https://reader035.fdocuments.us/reader035/viewer/2022062610/61206af755615573614597e4/html5/thumbnails/18.jpg)
Hydrocodone
• Only oral
• Always coupled with Acetaminophen or NSAID – until now.
• About equipotent with morphine
• The most commonly prescribed opioid
(Vicodin, Lortab, Norco, others)
![Page 19: Review of Pain Management with Clinical and Regulatory …capewayne.med.wayne.edu/pdfs/review_of_pain...Clinical and Regulatory Updates Palliative Care Collaborative: 8th Annual Regional](https://reader035.fdocuments.us/reader035/viewer/2022062610/61206af755615573614597e4/html5/thumbnails/19.jpg)
Adjuvant Analgesics • Anti-depressants - neuropathic
• Anti-convulsants - neuropathic
• Corticosteroids – bone mets, large tumors, bowel obstruction
• Nerve blocks
anesthetic
lytic
• Epidural, intrathecal
opiods
local anesthetics
• Nerve stimulators
![Page 20: Review of Pain Management with Clinical and Regulatory …capewayne.med.wayne.edu/pdfs/review_of_pain...Clinical and Regulatory Updates Palliative Care Collaborative: 8th Annual Regional](https://reader035.fdocuments.us/reader035/viewer/2022062610/61206af755615573614597e4/html5/thumbnails/20.jpg)
WHO Analgesic Ladder for Cancer Pain Management
• Pain - Non-opioid +/- adjuvant
• Pain persisting or increasing – low-dose opioid +/-non-opioid +/-adjuvant
• Pain persisting or increasing – increase dose of opioid +/- non-opioid ……..
• Freedom from pain
![Page 21: Review of Pain Management with Clinical and Regulatory …capewayne.med.wayne.edu/pdfs/review_of_pain...Clinical and Regulatory Updates Palliative Care Collaborative: 8th Annual Regional](https://reader035.fdocuments.us/reader035/viewer/2022062610/61206af755615573614597e4/html5/thumbnails/21.jpg)
Rational Use of Opioids
![Page 22: Review of Pain Management with Clinical and Regulatory …capewayne.med.wayne.edu/pdfs/review_of_pain...Clinical and Regulatory Updates Palliative Care Collaborative: 8th Annual Regional](https://reader035.fdocuments.us/reader035/viewer/2022062610/61206af755615573614597e4/html5/thumbnails/22.jpg)
![Page 23: Review of Pain Management with Clinical and Regulatory …capewayne.med.wayne.edu/pdfs/review_of_pain...Clinical and Regulatory Updates Palliative Care Collaborative: 8th Annual Regional](https://reader035.fdocuments.us/reader035/viewer/2022062610/61206af755615573614597e4/html5/thumbnails/23.jpg)
“Among the remedies which it has pleased Almighty God to give to man to relieve his
sufferings, none is so universal and so efficacious as opium.”
Thomas Sydenham
(17th century)
![Page 24: Review of Pain Management with Clinical and Regulatory …capewayne.med.wayne.edu/pdfs/review_of_pain...Clinical and Regulatory Updates Palliative Care Collaborative: 8th Annual Regional](https://reader035.fdocuments.us/reader035/viewer/2022062610/61206af755615573614597e4/html5/thumbnails/24.jpg)
“Among the remedies which it has pleased Almighty God to give to man to relieve his
sufferings, none is so universal and so efficacious as opium.”
Thomas Sydenham
(17th century)
“Amen”
Mike Stellini (2014)
![Page 25: Review of Pain Management with Clinical and Regulatory …capewayne.med.wayne.edu/pdfs/review_of_pain...Clinical and Regulatory Updates Palliative Care Collaborative: 8th Annual Regional](https://reader035.fdocuments.us/reader035/viewer/2022062610/61206af755615573614597e4/html5/thumbnails/25.jpg)
Opioids
1. Analgesia
2. Sedation
3. Respiratory Depression (RARE)
(These effects occur in this order!)
![Page 26: Review of Pain Management with Clinical and Regulatory …capewayne.med.wayne.edu/pdfs/review_of_pain...Clinical and Regulatory Updates Palliative Care Collaborative: 8th Annual Regional](https://reader035.fdocuments.us/reader035/viewer/2022062610/61206af755615573614597e4/html5/thumbnails/26.jpg)
Opioids
• Tolerance – need higher dose of drug to get same previous effect.
(In cancer patients, increased need often due to increased disease)
A cancer patient on 300 mg/day morphine wide awake; me – not likely.
• Physical Dependence – defined by abstinence/withdrawal syndrome
• Psychological dependence = addiction
![Page 27: Review of Pain Management with Clinical and Regulatory …capewayne.med.wayne.edu/pdfs/review_of_pain...Clinical and Regulatory Updates Palliative Care Collaborative: 8th Annual Regional](https://reader035.fdocuments.us/reader035/viewer/2022062610/61206af755615573614597e4/html5/thumbnails/27.jpg)
Opioids - Addiction
• Non-medicinal use
• Use despite negative physical, social, legal consequences
• Pre-occupation with obtaining the substance
• Not likely in cancer patients
![Page 28: Review of Pain Management with Clinical and Regulatory …capewayne.med.wayne.edu/pdfs/review_of_pain...Clinical and Regulatory Updates Palliative Care Collaborative: 8th Annual Regional](https://reader035.fdocuments.us/reader035/viewer/2022062610/61206af755615573614597e4/html5/thumbnails/28.jpg)
![Page 29: Review of Pain Management with Clinical and Regulatory …capewayne.med.wayne.edu/pdfs/review_of_pain...Clinical and Regulatory Updates Palliative Care Collaborative: 8th Annual Regional](https://reader035.fdocuments.us/reader035/viewer/2022062610/61206af755615573614597e4/html5/thumbnails/29.jpg)
Morphine
• Conjugated in liver.
• Morphine glucuronide is active.
• Excreted in urine.
• Decrease dose with renal impairment.
• May want to titrate dose down near end of life because of renal shut-down.
![Page 30: Review of Pain Management with Clinical and Regulatory …capewayne.med.wayne.edu/pdfs/review_of_pain...Clinical and Regulatory Updates Palliative Care Collaborative: 8th Annual Regional](https://reader035.fdocuments.us/reader035/viewer/2022062610/61206af755615573614597e4/html5/thumbnails/30.jpg)
Hydromorphone
• More potent than morphine
• Oral or IV
• Safer in renal disease
• Mostly hepatic metabolism
![Page 31: Review of Pain Management with Clinical and Regulatory …capewayne.med.wayne.edu/pdfs/review_of_pain...Clinical and Regulatory Updates Palliative Care Collaborative: 8th Annual Regional](https://reader035.fdocuments.us/reader035/viewer/2022062610/61206af755615573614597e4/html5/thumbnails/31.jpg)
Hydrocodone
• Only oral
• Coupled with Acetaminophen or NSAID
• About equipotent with morphine
• The most commonly prescribed opioid
(Vicodin, Lortab, Norco, others)
![Page 32: Review of Pain Management with Clinical and Regulatory …capewayne.med.wayne.edu/pdfs/review_of_pain...Clinical and Regulatory Updates Palliative Care Collaborative: 8th Annual Regional](https://reader035.fdocuments.us/reader035/viewer/2022062610/61206af755615573614597e4/html5/thumbnails/32.jpg)
Codeine
• Oral
• Coverts to morphine
• Effect ceiling (about 60 mg)
• Side effect ceiling higher than effect ceiling.
![Page 33: Review of Pain Management with Clinical and Regulatory …capewayne.med.wayne.edu/pdfs/review_of_pain...Clinical and Regulatory Updates Palliative Care Collaborative: 8th Annual Regional](https://reader035.fdocuments.us/reader035/viewer/2022062610/61206af755615573614597e4/html5/thumbnails/33.jpg)
Fentanyl
• Much more potent than morphine/hydromorphone
• Oral (lollipop, orally dissolving tabs)
• IV - less hemodynamic effects than morphine
• Transdermal – generally change every 72 hours; 80% of original dose remains in the “used” patch. Flush! (or sharps container)
![Page 34: Review of Pain Management with Clinical and Regulatory …capewayne.med.wayne.edu/pdfs/review_of_pain...Clinical and Regulatory Updates Palliative Care Collaborative: 8th Annual Regional](https://reader035.fdocuments.us/reader035/viewer/2022062610/61206af755615573614597e4/html5/thumbnails/34.jpg)
Meperidine
• Limited use – FORGET ABOUT IT!
• Toxic metabolite – normeperidine
seizures, hallucinations,
bronchospasm, Death.
• Some hospitals have eliminated from formulary
• APS Guidelines – procedure related pain;
<48 hrs.; <600mg; not for chronic or prolonged post-op pain.
![Page 35: Review of Pain Management with Clinical and Regulatory …capewayne.med.wayne.edu/pdfs/review_of_pain...Clinical and Regulatory Updates Palliative Care Collaborative: 8th Annual Regional](https://reader035.fdocuments.us/reader035/viewer/2022062610/61206af755615573614597e4/html5/thumbnails/35.jpg)
Methadone
• Unique opioid
• Intrinsically long half-life – can be problematic
• Multiple pain receptor activity (mu, delta, NMDA, serotonin and norepi reuptake)
• Inexpensive
• Probably best opioid for neuropathic pain
• Conversion ratio varies inversely with higher morphine doses
• Hepatic metabolism
![Page 36: Review of Pain Management with Clinical and Regulatory …capewayne.med.wayne.edu/pdfs/review_of_pain...Clinical and Regulatory Updates Palliative Care Collaborative: 8th Annual Regional](https://reader035.fdocuments.us/reader035/viewer/2022062610/61206af755615573614597e4/html5/thumbnails/36.jpg)
Conversion ratio of Morphine po to Methadone po
Daily MS po dose (mg)
< 100 mg
101 - 300 mg
301 - 600 mg
601 - 800 mg
801 - 1000 mg
> 1000 mg
Conversion ratio
3:1
5:1
10:1
12:1
15:1
20:1
![Page 37: Review of Pain Management with Clinical and Regulatory …capewayne.med.wayne.edu/pdfs/review_of_pain...Clinical and Regulatory Updates Palliative Care Collaborative: 8th Annual Regional](https://reader035.fdocuments.us/reader035/viewer/2022062610/61206af755615573614597e4/html5/thumbnails/37.jpg)
Methadone
Cautions: • Get supervised experience
• LONG half-life
• Only titrate every four days
• Very high doses – Qt prolongation/torsades de pointes (observed but rare)
![Page 38: Review of Pain Management with Clinical and Regulatory …capewayne.med.wayne.edu/pdfs/review_of_pain...Clinical and Regulatory Updates Palliative Care Collaborative: 8th Annual Regional](https://reader035.fdocuments.us/reader035/viewer/2022062610/61206af755615573614597e4/html5/thumbnails/38.jpg)
We can give you enough medicine
to alleviate the pain, but not enough
to make it fun.
![Page 39: Review of Pain Management with Clinical and Regulatory …capewayne.med.wayne.edu/pdfs/review_of_pain...Clinical and Regulatory Updates Palliative Care Collaborative: 8th Annual Regional](https://reader035.fdocuments.us/reader035/viewer/2022062610/61206af755615573614597e4/html5/thumbnails/39.jpg)
Opioids – Side Effects
• Constipation No tolerance Prophylax - Laxative (senna) and softener (docusate). Treatment – Other stimulants (bicosadyl) Osmotics (lactulose, Miralax) Mg Citrate, Enemas Methylnaltrexone (new) sub-Q injection, non-centrally acting mu receptor antagonist
![Page 40: Review of Pain Management with Clinical and Regulatory …capewayne.med.wayne.edu/pdfs/review_of_pain...Clinical and Regulatory Updates Palliative Care Collaborative: 8th Annual Regional](https://reader035.fdocuments.us/reader035/viewer/2022062610/61206af755615573614597e4/html5/thumbnails/40.jpg)
Opioids - Side Effects
• Pruritis – probably most common with morphine Not thought to be histamine mediated Treat with ondansetron or naltrexone or change drug.
![Page 41: Review of Pain Management with Clinical and Regulatory …capewayne.med.wayne.edu/pdfs/review_of_pain...Clinical and Regulatory Updates Palliative Care Collaborative: 8th Annual Regional](https://reader035.fdocuments.us/reader035/viewer/2022062610/61206af755615573614597e4/html5/thumbnails/41.jpg)
Opioids - Side Effects
• Nausea
• Sedation (consider methylphenidate)
• Respiratory depression
TOLERANCE DEVELOPS TO ALL
![Page 42: Review of Pain Management with Clinical and Regulatory …capewayne.med.wayne.edu/pdfs/review_of_pain...Clinical and Regulatory Updates Palliative Care Collaborative: 8th Annual Regional](https://reader035.fdocuments.us/reader035/viewer/2022062610/61206af755615573614597e4/html5/thumbnails/42.jpg)
Opioids - Side Effects
• Neuro/neuro-excitatory effects –sedation, confusion, delirium;
• High dose - myoclonus can develop and may be a dose limiting effect of morphine
- May want to add benzodiazepine
- Switch opioid. Methadone may be best
alternative
![Page 43: Review of Pain Management with Clinical and Regulatory …capewayne.med.wayne.edu/pdfs/review_of_pain...Clinical and Regulatory Updates Palliative Care Collaborative: 8th Annual Regional](https://reader035.fdocuments.us/reader035/viewer/2022062610/61206af755615573614597e4/html5/thumbnails/43.jpg)
Opioids - Side Effects
Hyperalgesia
• Allodynia – Painful sensation from normally non-painful stimulus
• Hyperesthesia – dramatically increased sensitivity to painful stimulus
• ?related to tolerance
![Page 44: Review of Pain Management with Clinical and Regulatory …capewayne.med.wayne.edu/pdfs/review_of_pain...Clinical and Regulatory Updates Palliative Care Collaborative: 8th Annual Regional](https://reader035.fdocuments.us/reader035/viewer/2022062610/61206af755615573614597e4/html5/thumbnails/44.jpg)
![Page 45: Review of Pain Management with Clinical and Regulatory …capewayne.med.wayne.edu/pdfs/review_of_pain...Clinical and Regulatory Updates Palliative Care Collaborative: 8th Annual Regional](https://reader035.fdocuments.us/reader035/viewer/2022062610/61206af755615573614597e4/html5/thumbnails/45.jpg)
Opioid Pharmacokinetics
![Page 46: Review of Pain Management with Clinical and Regulatory …capewayne.med.wayne.edu/pdfs/review_of_pain...Clinical and Regulatory Updates Palliative Care Collaborative: 8th Annual Regional](https://reader035.fdocuments.us/reader035/viewer/2022062610/61206af755615573614597e4/html5/thumbnails/46.jpg)
Opioid Pharmacokinetics
Oral • Short acting - almost all opioids
oral dose - peak 90 minutes
duration 2-4 hours
• Methadone - intinsically long acting
accumulates with repeat dosing
• Long acting preps - morphine, oxycodone
fentanyl (patch)
![Page 47: Review of Pain Management with Clinical and Regulatory …capewayne.med.wayne.edu/pdfs/review_of_pain...Clinical and Regulatory Updates Palliative Care Collaborative: 8th Annual Regional](https://reader035.fdocuments.us/reader035/viewer/2022062610/61206af755615573614597e4/html5/thumbnails/47.jpg)
Opioid Pharmacology Oral
• Dose escalation - 1-2 hours
mild/mod pain - 25% - 50%
severe pain 50% - 100%
• Maximum dose -
none except meperidine (avoid),
propoxyphene (now off the market),
combo with APAP, NSAID
![Page 48: Review of Pain Management with Clinical and Regulatory …capewayne.med.wayne.edu/pdfs/review_of_pain...Clinical and Regulatory Updates Palliative Care Collaborative: 8th Annual Regional](https://reader035.fdocuments.us/reader035/viewer/2022062610/61206af755615573614597e4/html5/thumbnails/48.jpg)
Opioid Pharmacokinetics Intravenous
• Push - Peaks in 6-10 min. IV; 30 min. subQ/IM
• Continuous - Give a loading bolus at the start and with each increase in basal rate
• Administer bolus slowly
![Page 49: Review of Pain Management with Clinical and Regulatory …capewayne.med.wayne.edu/pdfs/review_of_pain...Clinical and Regulatory Updates Palliative Care Collaborative: 8th Annual Regional](https://reader035.fdocuments.us/reader035/viewer/2022062610/61206af755615573614597e4/html5/thumbnails/49.jpg)
Pla
sma
Co
nce
ntr
atio
n
0 Half-life (t1/2) Time
IV
po / pr
SC / IM
Cmax
![Page 50: Review of Pain Management with Clinical and Regulatory …capewayne.med.wayne.edu/pdfs/review_of_pain...Clinical and Regulatory Updates Palliative Care Collaborative: 8th Annual Regional](https://reader035.fdocuments.us/reader035/viewer/2022062610/61206af755615573614597e4/html5/thumbnails/50.jpg)
Switching Opioids
• Use conversion table (see handout)
• Allow for incomplete cross-tolerance
start with 50 - 75% of published dose (“safety factor”)
• Transdermal Fentanyl -
Approx 50 – 100 mg morphine/day ->
25 mcg/hr patch
(Difficult to calculate in reverse)
![Page 51: Review of Pain Management with Clinical and Regulatory …capewayne.med.wayne.edu/pdfs/review_of_pain...Clinical and Regulatory Updates Palliative Care Collaborative: 8th Annual Regional](https://reader035.fdocuments.us/reader035/viewer/2022062610/61206af755615573614597e4/html5/thumbnails/51.jpg)
Equi-analgesic Ratios
Oral Parenteral
Morphine 30mg 10mg
Hydrocodone 30mg -
Oxycodone 20mg -
Hydromorphone 7.5 1.5
![Page 52: Review of Pain Management with Clinical and Regulatory …capewayne.med.wayne.edu/pdfs/review_of_pain...Clinical and Regulatory Updates Palliative Care Collaborative: 8th Annual Regional](https://reader035.fdocuments.us/reader035/viewer/2022062610/61206af755615573614597e4/html5/thumbnails/52.jpg)
Opioids and Chronic Pain
Getting started • Start with short acting to determine need and
tolerance
• Don’t start an opioid naïve patient on long acting first! (How do you know where to start?)
• Mild/elderly w/moderate pain: 2-5 mg morphine every three hours PRN
• Moderate to severe pain: 5 -10 mg morphine
• If pt has known pre-existing tolerance start higher
![Page 53: Review of Pain Management with Clinical and Regulatory …capewayne.med.wayne.edu/pdfs/review_of_pain...Clinical and Regulatory Updates Palliative Care Collaborative: 8th Annual Regional](https://reader035.fdocuments.us/reader035/viewer/2022062610/61206af755615573614597e4/html5/thumbnails/53.jpg)
Opioids and Chronic Pain
• Escalate dose at appropriate interval until pain relief achieved
• For oral – determine 24 hr need after 24-48 hours. This determines long acting daily dose.
• For IV – find effective bolus dose and start continuous at half of bolus.
• Monitor effect and side effects carefully
![Page 54: Review of Pain Management with Clinical and Regulatory …capewayne.med.wayne.edu/pdfs/review_of_pain...Clinical and Regulatory Updates Palliative Care Collaborative: 8th Annual Regional](https://reader035.fdocuments.us/reader035/viewer/2022062610/61206af755615573614597e4/html5/thumbnails/54.jpg)
Opioids and Chronic Pain
• Long acting plus short acting for breakthrough q. 1-2 hrs. (10-20% of 24 hr. oral dose)
• Continuous IV – breakthrough dose is usually about 50% of hourly rate q 10 minutes.
• Observe closely and adjust dose and frequency based on effect and side effects
![Page 55: Review of Pain Management with Clinical and Regulatory …capewayne.med.wayne.edu/pdfs/review_of_pain...Clinical and Regulatory Updates Palliative Care Collaborative: 8th Annual Regional](https://reader035.fdocuments.us/reader035/viewer/2022062610/61206af755615573614597e4/html5/thumbnails/55.jpg)
Opioids and Chronic Pain
• If frequent breakthrough dosing needed, adjust daily long acting/continuous dose.
• Monitor and control side effects
constipation - treat proactively
nausea - short lived
pruritis - ondansetron
resp depression - RARE with proper
titration
![Page 56: Review of Pain Management with Clinical and Regulatory …capewayne.med.wayne.edu/pdfs/review_of_pain...Clinical and Regulatory Updates Palliative Care Collaborative: 8th Annual Regional](https://reader035.fdocuments.us/reader035/viewer/2022062610/61206af755615573614597e4/html5/thumbnails/56.jpg)
Opioids and Chronic Pain
• One long acting
• One short acting
• Opioid rotation may be needed if high doses are reached and pain not very well controlled
• NOTE: doses of morphine required for relief of dyspnea are usually smaller than those used for pain.
![Page 57: Review of Pain Management with Clinical and Regulatory …capewayne.med.wayne.edu/pdfs/review_of_pain...Clinical and Regulatory Updates Palliative Care Collaborative: 8th Annual Regional](https://reader035.fdocuments.us/reader035/viewer/2022062610/61206af755615573614597e4/html5/thumbnails/57.jpg)
Opioids - Withdrawal
• Cruel to let patient withdrawal • Dilated pupils, piloerection, nasal flaring ABDOMINAL PAIN • Avoid naloxone if at all possible. • If used – dilute, administer slowly • Naloxone has short half-life. If used for a
patient overdosed on long acting opioid, overdose side-effects will recur when naloxone wears off.
![Page 58: Review of Pain Management with Clinical and Regulatory …capewayne.med.wayne.edu/pdfs/review_of_pain...Clinical and Regulatory Updates Palliative Care Collaborative: 8th Annual Regional](https://reader035.fdocuments.us/reader035/viewer/2022062610/61206af755615573614597e4/html5/thumbnails/58.jpg)
Opioid rotation
• Improved pain control
• Incomplete cross tolerance
• Conversion charts
• Decrease dose
![Page 59: Review of Pain Management with Clinical and Regulatory …capewayne.med.wayne.edu/pdfs/review_of_pain...Clinical and Regulatory Updates Palliative Care Collaborative: 8th Annual Regional](https://reader035.fdocuments.us/reader035/viewer/2022062610/61206af755615573614597e4/html5/thumbnails/59.jpg)
Bone Pain
• NSAIDS
• Corticosteroids
• Plus opioids
• Bisphosphenates
![Page 60: Review of Pain Management with Clinical and Regulatory …capewayne.med.wayne.edu/pdfs/review_of_pain...Clinical and Regulatory Updates Palliative Care Collaborative: 8th Annual Regional](https://reader035.fdocuments.us/reader035/viewer/2022062610/61206af755615573614597e4/html5/thumbnails/60.jpg)
Recent Regulatory Activity
• Based on:
Increasing deaths due to hydrocodone, methadone overdoses, common/inappropriate prescribing – primarily hydrocodone, misuse of sustained/extended release preparations
• Heroin overdoses also increased
![Page 61: Review of Pain Management with Clinical and Regulatory …capewayne.med.wayne.edu/pdfs/review_of_pain...Clinical and Regulatory Updates Palliative Care Collaborative: 8th Annual Regional](https://reader035.fdocuments.us/reader035/viewer/2022062610/61206af755615573614597e4/html5/thumbnails/61.jpg)
Recent Regulatory Activity
• REMS • Hydrocodone – re-scheduled to Schedule 2 No refills, no phone-ins • Acetaminophen content of hydrocodone/APAP
limited to 325 mg per dose • “Extra-strength Tylenol” – rec only 3 gm/day max. • New drug – hydrocodone extended release
“Zohydro” • Tramadol rescheduled to Schedule 4 • Tamper-proof ER preparations – NOT Zohydro!
![Page 62: Review of Pain Management with Clinical and Regulatory …capewayne.med.wayne.edu/pdfs/review_of_pain...Clinical and Regulatory Updates Palliative Care Collaborative: 8th Annual Regional](https://reader035.fdocuments.us/reader035/viewer/2022062610/61206af755615573614597e4/html5/thumbnails/62.jpg)
![Page 63: Review of Pain Management with Clinical and Regulatory …capewayne.med.wayne.edu/pdfs/review_of_pain...Clinical and Regulatory Updates Palliative Care Collaborative: 8th Annual Regional](https://reader035.fdocuments.us/reader035/viewer/2022062610/61206af755615573614597e4/html5/thumbnails/63.jpg)